The ERK signaling target RNF126 regulates anoikis resistance in cancer cells by changing the mitochondrial metabolic flux

por Yoshino, Seiko, Hara, Toshiro, Nakaoka, Hiroki J, Kanamori, Akane, Murakami, Yoshinori, Seiki, Motoharu, Sakamoto, Takeharu
Publicado 2016

NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells

por Nakaoka, Hiroki J., Hara, Toshiro, Yoshino, Seiko, Kanamori, Akane, Matsui, Yusuke, Shimamura, Teppei, Sato, Hiroshi, Murakami, Yoshinori, Seiki, Motoharu, Sakamoto, Takeharu
Publicado 2016

Mint3 depletion restricts tumor malignancy of pancreatic cancer cells by decreasing SKP2 expression via HIF-1

por Kanamori, Akane, Matsubara, Daisuke, Saitoh, Yurika, Fukui, Yuya, Gotoh, Noriko, Kaneko, Shuichi, Seiki, Motoharu, Murakami, Yoshinori, Inoue, Jun-ichiro, Sakamoto, Takeharu
Publicado 2020

EXOSC9 depletion attenuates P-body formation, stress resistance, and tumorigenicity of cancer cells

por Yoshino, Seiko, Matsui, Yusuke, Fukui, Yuya, Seki, Masahide, Yamaguchi, Kiyoshi, Kanamori, Akane, Saitoh, Yurika, Shimamura, Teppei, Suzuki, Yutaka, Furukawa, Yoichi, Kaneko, Shuichi, Seiki, Motoharu, Murakami, Yoshinori, Inoue, Jun-ichiro, Sakamoto, Takeharu
Publicado 2020